Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| 1 |
Apple
AAPL
|
+$1.37B |
| 2 |
Schwab Intermediately-Term US Treasury ETF
SCHR
|
+$1.24B |
| 3 |
Chevron
CVX
|
+$472M |
| 4 |
Pfizer
PFE
|
+$372M |
| 5 |
Amazon
AMZN
|
+$369M |
Top Sells
| 1 |
Schwab US Large- Cap ETF
SCHX
|
+$9.58B |
| 2 |
Schwab 5-10 Year Corporate Bond ETF
SCHI
|
+$5.28B |
| 3 |
Schwab International Equity ETF
SCHF
|
+$4.53B |
| 4 |
Schwab U.S Small- Cap ETF
SCHA
|
+$4.13B |
| 5 |
Schwab Emerging Markets Equity ETF
SCHE
|
+$2.63B |
Sector Composition
| 1 | Technology | 22.61% |
| 2 | Financials | 12.09% |
| 3 | Healthcare | 10.58% |
| 4 | Consumer Discretionary | 9.24% |
| 5 | Industrials | 8.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1901
MaxLinear
MXL
$1.37B
| $13.3M | ﹤0.01% |
915,415
+145,695
| +19% | +$2.11M |
|
1902
Live Oak Bancshares
LOB
$1.67B
| $13.2M | ﹤0.01% |
278,821
+8,116
| +3% | +$384K |
|
1903
Golar LNG
GLNG
$4.16B
| $13.2M | ﹤0.01% |
358,997
-58,616
| -14% | -$2.15M |
|
1904
FIVE9
FIVN
$2B
| $13.1M | ﹤0.01% |
457,257
-17,400
| -4% | -$500K |
|
|
AAMI
1905
Acadian Asset Management Inc.
AAMI
$1.74B
| $13.1M | ﹤0.01% |
515,990
-127,084
| -20% | -$3.23M |
|
1906
PACS Group
PACS
$1.51B
| $13.1M | ﹤0.01% |
327,005
+143,389
| +78% | +$5.73M |
|
1907
Arvinas
ARVN
$568M
| $13.1M | ﹤0.01% |
530,669
-13,834
| -3% | -$341K |
|
1908
Hain Celestial
HAIN
$194M
| $13.1M | ﹤0.01% |
1,514,178
-259,000
| -15% | -$2.24M |
|
1909
Par Pacific Holdings
PARR
$1.67B
| $13.1M | ﹤0.01% |
741,626
+13,457
| +2% | +$237K |
|
1910
Enviri
NVRI
$983M
| $13M | ﹤0.01% |
1,261,379
-242,406
| -16% | -$2.51M |
|
1911
NovoCure
NVCR
$1.36B
| $12.9M | ﹤0.01% |
824,443
+16,339
| +2% | +$255K |
|
1912
Beazer Homes USA
BZH
$781M
| $12.9M | ﹤0.01% |
376,365
-66,534
| -15% | -$2.27M |
|
1913
QuantumScape
QS
$5.63B
| $12.8M | ﹤0.01% |
2,227,072
+93,826
| +4% | +$540K |
|
1914
Mirum Pharmaceuticals
MIRM
$3.73B
| $12.8M | ﹤0.01% |
328,161
+17,149
| +6% | +$669K |
|
1915
Recursion Pharmaceuticals
RXRX
$2.11B
| $12.8M | ﹤0.01% |
1,940,680
+288,926
| +17% | +$1.9M |
|
1916
John B. Sanfilippo & Son
JBSS
$737M
| $12.8M | ﹤0.01% |
135,373
-390
| -0.3% | -$36.8K |
|
1917
iShares Core S&P US Value ETF
IUSV
$22.1B
| $12.7M | ﹤0.01% |
132,759
-52,641
| -28% | -$5.03M |
|
1918
SiriusPoint
SPNT
$2.22B
| $12.7M | ﹤0.01% |
883,749
+63,186
| +8% | +$906K |
|
1919
Trupanion
TRUP
$1.87B
| $12.6M | ﹤0.01% |
300,414
-6,112
| -2% | -$257K |
|
1920
Xencor
XNCR
$613M
| $12.6M | ﹤0.01% |
626,988
+40,788
| +7% | +$820K |
|
1921
US Physical Therapy
USPH
$1.22B
| $12.6M | ﹤0.01% |
148,901
-6,140
| -4% | -$520K |
|
1922
Tecnoglass
TGLS
$3.32B
| $12.6M | ﹤0.01% |
183,400
+13,803
| +8% | +$948K |
|
1923
Avanos Medical
AVNS
$567M
| $12.6M | ﹤0.01% |
523,494
-44,734
| -8% | -$1.07M |
|
1924
Arlo Technologies
ARLO
$1.82B
| $12.6M | ﹤0.01% |
1,036,400
+14,308
| +1% | +$173K |
|
|
RDFN
1925
DELISTED
Redfin
RDFN
| $12.5M | ﹤0.01% |
998,284
+92,023
| +10% | +$1.15M |
|